All Episodes
|
185
|
David C. Radley, Ph.D., M.P.H.

Podcast 185: Better Health Policy Starts with Better Data w/ David C. Radley, Ph.D., M.P.H.

Jun 5, 2025

Episode Summary

What happens when state health policymakers lose access to the very data they rely on?In this episode of Health Care Rounds, John Marchica talks with Dr. David Radley, Director of Data and Analytics at The Center for Evidence-Based Policy and Senior Scientist at the Commonwealth Fund. They explore how states use administrative data to make informed Medicaid decisions, and why recent threats to public data infrastructure could undermine that progress.Dr. Radley breaks down how his team turns raw data into actionable insights, how states are planning for the financial impact of high-cost therapies, and why cutting long-standing federal data sets could cripple efforts to address health disparities.

Episode Notes

What happens when state health policymakers lose access to the very data they rely on?

In this episode of Health Care Rounds, John Marchica talks with David C. Radley, Ph.D., M.P.H., Director of Data and Analytics at The Center for Evidence-Based Policy and Senior Scientist at the Commonwealth Fund. They explore how states use administrative data to make informed Medicaid decisions, and why recent threats to public data infrastructure could undermine that progress.

Dr. Radley breaks down how his team turns raw data into actionable insights, how states are planning for the financial impact of high-cost therapies, and why cutting long-standing federal data sets could cripple efforts to address health disparities.


🎙 ABOUT DAVID C. RADLEY
David C. Radley is the Center’s inaugural Director of Data and Analytics. Dr. Radley has 18 years of experience in health policy evaluation, quality and performance measurement, and in public reporting and visualization of healthcare data. Prior to joining the Center, David served as scientific lead for the Commonwealth Fund’s Health System Performance Tracking initiative, where he was responsible for defining national, state, and sub-state performance evaluations; measure selection and development; procuring and analyzing relevant data; and curating performance information for visualization and public reporting. He has authored over 50 articles, issue briefs, and technical reports focusing on access to care, healthcare affordability, healthcare quality, health equity, and population health outcomes. Dr. Radley received his PhD in Health Policy from the Dartmouth Institute for Health Policy and Clinical Practice and M.P.H. from Yale University. As Director of Data and Analytics, Dr. Radley will direct data related research and build the Center’s capacity to meet the growing data needs of states.

🎙 ABOUT HEALTH CARE ROUNDS
Health Care Rounds is a weekly podcast developed for health care leaders who are at the forefront of health care delivery and payment reform. Join Darwin Research Group founder and CEO John Marchica as he discusses the latest advancements in health care business news and policy developments.

CONNECT WITH US:

🌐 Visit us on the web

🌐 Follow Health Care Rounds on LinkedIn

🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube

🎧 Listen on Apple Podcasts

🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media

Recommended Next

Podcast 197: Making Health Care Costs Simple and Transparent w/ Mark Cuban, Co-Founder, Cost Plus Drugs
Podcast 196: Physician Leadership in a New Era of Health Care w/ Dr. Sowmya Viswanathan, Baycare
Podcast 195: Why Primary Care Is Under Strain w/ Dr. Greg Whisman, Chief Medical Officer, CareMore Health
Podcast 194: Why Health Care Reform Keeps Failing w/ Dr. David Shulkin
Podcast 193: The New Model for Specialty Pharmacy w/ Jigar Thakkar, PharmD
Podcast 192: Making Value-Based Care Work at Scale w/ David Carmouche, MD
Podcast 191: Curing Nursing Burnout Through Education w/ Dr. Adele Webb
Podcast 190: The New Rules of Health System Leadership w/ John D’Angelo, MD, FACEP

Recommended Content

Browse Library
INsights
January 14, 2026

Darwin's Our Take: Lilly’s ‘triple G’ candidate exceeds analysts’ expectations

Read More
INsights
January 5, 2026

Darwin's Our Take: FDA approves Novo Nordisk’s Wegovy pill

Read More
INsights
December 22, 2025

Darwin's Our Take: Another 9 drugmakers agree to most-favored-nation pricing on certain products

Read More
Stay Aware. Stay Informed.

Subscribe to Our Take

Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.